|
|
||||||||
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892
Human airway epithelial cell
release of interleukin (IL)-6 in response to lipid mediators was
studied in an airway cell line (BEAS-2B). Prostaglandin (PG)
E2 (10
7 M) treatment caused an increase in
IL-6 release at 2, 4, 8, and 24 h. IL-6 release into the culture
medium at 24 h was 3,396 ± 306 vs. 1,051 ± 154 pg/ml
(PGE2-treated cells vs. control cells). PGE2
(10
7 to 10
10 M) induced a dose-related
increase in IL-6 release at 24 h. PGF2
(10
6 M) treatment caused a similar effect to that of
PGE2 (10
7 M). PGE2 analogs with
relative selectivity for PGE2 receptor subtypes were
studied. Sulprostone, a selective agonist for the EP-3 receptor subtype
had no effect on IL-6 release.
11-Deoxy-16,16-dimethyl-PGE2, an EP-2/4 agonist, and
17-phenyl trinor PGE2, an agonist selective for the
EP-1 > EP-3 receptor subtype (10
6 to
10
8 M), caused dose-dependent increases in IL-6 release.
8-Bromo-cAMP treatment resulted in dose-related increases in IL-6
release. RT-PCR of BEAS-2B cell mRNA demonstrated mRNA for EP-1, EP-2, and EP-4 receptors. After PGE2 treatment, increases in IL-6
mRNA were noted at 4 and 18 h. Therefore, PGE2
increases airway epithelial cell IL-6 production and release.
cytokines; eicosanoids; lung inflammation
This article has been cited by other articles:
![]() |
C. D. Douillet, W. P. Robinson III, P. M. Milano, R. C. Boucher, and P. B. Rich Nucleotides induce IL-6 release from human airway epithelia via P2Y2 and p38 MAPK-dependent pathways Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L734 - L746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Medjane, B. Raymond, Y. Wu, and L. Touqui Impact of CFTR {Delta}F508 mutation on prostaglandin E2 production and type IIA phospholipase A2 expression by pulmonary epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L816 - L824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Jeng, Y.-J. Wang, B.-L. Chiang, P.-H. Lee, C.-P. Chan, Y.-S. Ho, T.-M. Wang, J.-J. Lee, L.-J. Hahn, and M.-C. Chang Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-{alpha} production of oral epithelial cells by areca nut extract and arecoline Carcinogenesis, August 1, 2003; 24(8): 1301 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-D. Kim, E.-J. Kwon, D.-W. Park, S.-Y. Song, S.-K. Yoon, and S.-H. Baek Interleukin-1beta Induces MUC2 and MUC5AC Synthesis through Cyclooxygenase-2 in NCI-H292 Cells Mol. Pharmacol., November 1, 2002; 62(5): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Moon and J. J. Pestka Vomitoxin-Induced Cyclooxygenase-2 Gene Expression in Macrophages Mediated by Activation of ERK and p38 but Not JNK Mitogen-Activated Protein Kinases Toxicol. Sci., October 1, 2002; 69(2): 373 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Asokananthan, P. T. Graham, J. Fink, D. A. Knight, A. J. Bakker, A. S. McWilliam, P. J. Thompson, and G. A. Stewart Activation of Protease-Activated Receptor (PAR)-1, PAR-2, and PAR-4 Stimulates IL-6, IL-8, and Prostaglandin E2 Release from Human Respiratory Epithelial Cells J. Immunol., April 1, 2002; 168(7): 3577 - 3585. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |